HomeEmployersIMVT Corporation
I

IMVT Corporation

6 open positions
Last updated Oct 13, 2026
Remote90%
Hybrid5%
On-site5%
Salary shown100%
Avg. listing71d
This month1 new · 1 closed
I
IMVT Corporation··Remote · Worldwide

Director, Financial Planning & Analysis

$200k–$240k/year
80
High

Immunovant, Inc. is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases and is a majority-owned subsidiary of Roivant (Nasdaq: ROIV). As a trailblazer in anti-FcRn technology, the Company is developing innovative, targeted therapies to meet the

Finance & AccountingFinancial PlanningExecutive
See 2 similar>
2 0 0 New 11h ago
I
IMVT Corporation··Remote · Worldwide

Associate Director, Supply Chain Product Planning

$170k–$190k/year
43
Low

Immunovant, Inc. is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases and is a majority-owned subsidiary of Roivant (Nasdaq: ROIV). As a trailblazer in anti-FcRn technology, the Company is developing innovative, targeted therapies to meet the

OtherSupply ChainExecutive
See 2 similar>
8 0 0 1mo ago

Executive Assistant

$125k–$150k/year
34
Lowest

Immunovant, Inc. is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases and is a majority-owned subsidiary of Roivant (Nasdaq: ROIV). As a trailblazer in anti-FcRn technology, the Company is developing innovative, targeted therapies to meet the

Executive AssistantAdministration & Office SupportMid
See 2 similar>
4 0 0 2mo ago
I
IMVT Corporation··Remote · Worldwide

Senior Director, Biostatistics

$270k–$310k/year
43
Low

Immunovant, Inc. is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases and is a majority-owned subsidiary of Roivant (Nasdaq: ROIV). As a trailblazer in anti-FcRn technology, the Company is developing innovative, targeted therapies to meet the

OtherDirectorSenior
See 2 similar>
3 0 0 3mo ago
I
IMVT Corporation·Southeast·Remote · Worldwide

Director, Medical Science Liaison (MSL)

$230k–$250k/year
43
Low

Immunovant, Inc. is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases and is a majority-owned subsidiary of Roivant (Nasdaq: ROIV). As a trailblazer in anti-FcRn technology, the Company is developing innovative, targeted therapies to meet the

OtherMedical Science LiaisonExecutive
See 2 similar>
2 0 0 5mo ago
I
IMVT Corporation·United StatesUnited States·New York·Remote · Worldwide

Director, Marketing

$210k–$250k/year
43
Low

Immunovant, Inc. is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases and is a majority-owned subsidiary of Roivant (Nasdaq: ROIV). As a trailblazer in anti-FcRn technology, the Company is developing innovative, targeted therapies to meet the

OtherDirectorExecutive
See 2 similar>
7 0 0 ~6mo ago